31 Mar 2022 16:09
Craneware plc
("Craneware" or the "Company" or the "Group")
Total Voting Rights
As at 31 March 2022, the Company's issued share capital consisted of 35,542,169 ordinary shares of 1 pence each ("Ordinary Shares") all with voting rights. No shares are currently held in treasury. The total number of voting rights in the Company as at 31 March 2022 is therefore 35,542,169.
The above figure (35,542,169 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company.
For further information, please contact:
| |
Craneware plc | +44 (0)131 550 3100 |
Keith Neilson, CEO | |
Craig Preston, CFO | |
Alma (Financial PR) | +44 (0)20 3405 0205 |
Caroline Forde, Hilary Buchanan, Joe Pederzolli | craneware@almapr.co.uk |
Peel Hunt (NOMAD and Joint Broker) | +44 (0)20 7418 8900 |
Dan Webster, Andrew Clark | |
Investec Bank PLC (Joint Broker) | +44 (0)20 7597 5970 |
Patrick Robb, Henry Reast, Sebastian Lawrence | |
| |
Berenberg (Joint Broker) | +44 (0)20 3207 7800 |
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff |
About Craneware
We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.
Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.
Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2,000 U.S hospitals and health systems and almost 10,000 clinics and affiliated retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.
Learn more at www.craneware.com
Craneware (CRW)